{"classes":[{"categories":[{"measurements":[{"comment":"Not estimable due to the low number of events","groupId":"OG000","lowerLimit":"5.4","upperLimit":"NA","value":"25.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"}],"units":"Participants"}],"description":"DOR was defined as the duration of response from first response (CR/PR) to disease progression or death, whichever occurs first. CR or PR according to the IWC 2014 criteria was assessed by an IOERC.","dispersionType":"95% Confidence Interval","groups":[{"description":"HBI-8000 Tablets","id":"OG000","title":"HBI-8000"}],"paramType":"MEDIAN","populationDescription":"Subjects who achieved PR or CR in the PPS","reportingStatus":"POSTED","timeFrame":"Up to approximately 47 months.","title":"Median Duration of Response (DOR)","type":"SECONDARY","unitOfMeasure":"Months"}